Evidence map›Paper›PMID 32859966›Full record

ArticleCommunications biology2020

Loss of β-cell identity and diabetic phenotype in mice caused by disruption of CNOT3-dependent mRNA deadenylation.

Dina Mostafa, Akiko Yanagiya, Eleni Georgiadou, Yibo Wu, Theodoros Stylianides, Guy A Rutter, Toru Suzuki, Tadashi Yamamoto

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. TheBiomolecules · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Regulation of Early Lymphocyte DevelopmentFrontiers in immunology · 2021
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Dina MostafaCell Signal Unit, Okinawa Institute of Science and Technology Graduate University, Okinawa, Japan.ORCID http://orcid.org/0000-0002-9627-6372
Akiko YanagiyaCell Signal Unit, Okinawa Institute of Science and Technology Graduate University, Okinawa, Japan.ORCID http://orcid.org/0000-0002-5553-0311
Eleni GeorgiadouSection of Cell Biology and Functional Genomics, Department of Metabolism, Digestion and Reproduction, Imperial College London, Hammersmith Hospital, London, UK.ORCID http://orcid.org/0000-0003-4732-3678
Yibo WuLaboratory for Next-Generation Proteomics, Riken Center of Integrative Medical Sciences, Yokohama, Japan.
Theodoros StylianidesCentre of Innovative and Collaborative Construction Engineering, Loughborough University, Leicestershire, UK.
Guy A RutterSection of Cell Biology and Functional Genomics, Department of Metabolism, Digestion and Reproduction, Imperial College London, Hammersmith Hospital, London, UK.ORCID http://orcid.org/0000-0001-6360-0343
Toru SuzukiLaboratory for Immunogenetics, Riken Center of Integrative Medical Sciences, Yokohama, Japan. toru.suzuki.ff@riken.jp.ORCID http://orcid.org/0000-0003-1864-8027
Tadashi YamamotoCell Signal Unit, Okinawa Institute of Science and Technology Graduate University, Okinawa, Japan. tadashi.yamamoto@oist.jp.ORCID http://orcid.org/0000-0002-5938-9378
Hammersmith Hospital · GBOkinawa Institute of Science and Technology Graduate University · JPRIKEN Center for Integrative Medical Sciences · JPAin Shams University · EGLoughborough University · GB

Funding

Medical Research Council MR/J0003042/1Medical Research Council MR/K001981/1Medical Research Council MR/K023667/1Medical Research Council MR/L020149/1Medical Research Council MR/L02036X/1Medical Research Council MR/M012646/1Medical Research Council MR/N00275X/1Medical Research Council MR/N020472/1Medical Research Council MR/R010676/1Medical Research Council MR/R022259/1Medical Research Council MR/S025618/1Wellcome TrustWellcome Trust 212625/Z/18/Z
6 · The paper itself

Abstract

Pancreatic β-cells are responsible for production and secretion of insulin in response to increasing blood glucose levels. Defects in β-cell function lead to hyperglycemia and diabetes mellitus. Here, we show that CNOT3, a CCR4-NOT deadenylase complex subunit, is dysregulated in islets in diabetic db/db mice, and that it is essential for murine β cell maturation and identity. Mice with β cell-specific Cnot3 deletion (Cnot3βKO) exhibit impaired glucose tolerance, decreased β cell mass, and they gradually develop diabetes. Cnot3βKO islets display decreased expression of key regulators of β cell maturation and function. Moreover, they show an increase of progenitor cell markers, β cell-disallowed genes, and genes relevant to altered β cell function. Cnot3βKO islets exhibit altered deadenylation and increased mRNA stability, partly accounting for the increased expression of those genes. Together, these data reveal that CNOT3-mediated mRNA deadenylation and decay constitute previously unsuspected post-transcriptional mechanisms essential for β cell identity.

Indexed as

AnimalsCell CountCell DifferentiationDiabetes Mellitus, ExperimentalDisease Models, AnimalGlucoseGlucose Tolerance TestInsulinInsulin-Secreting CellsInsulin SecretionLipidsMaleMice, KnockoutModels, BiologicalObesityPhenotypeCNOT3 protein, mouseGlucoseInsulinLipidsProteomeRNA, MessengerTranscription Factors

Identifiers

PMID32859966
PMCPMC7455721
OpenAlexW3081725104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.